Latest Updates

When a person develops solid tumors in the stomach or esophagus or rectum, oncologists know how to treat them.

In rural Colorado, where hospital closures and provider shortages threaten access to care, the federal 340B Drug Pricing Program is a lifeline.

WASHINGTON – Today, U.S. Senator Bill Cassidy, M.D. (R-LA), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, released a report detailing findings from his years’ long investigation into how covered entities use and generate revenue from the 340B Drug Pricing Program. Cassidy also outlined potential reforms needed to improve the program to better serve patients.

A new report on the 340B Drug Pricing Program released Thursday by the chairman of the Senate Health, Education, Labor and Pensions Committee calls for “much-needed” legislative reforms around transparency and oversight of the contentious discount program.

There are significant differences in the costs and durations of radiotherapy treatment for cancer, depending on whether a patient is insured by traditional Medicare (TM) or Medicare Advantage (MA), according to a new study by health policy researchers at Harvard T.H. Chan School of Public Health.

WASHINGTON, DC, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- The National Cancer Treatment Alliance (NCTA), a national network of independent community oncology practices working to increase access to high-quality and local cancer care, announced today that it has partnered with XO Health to provide employers access to NCTA’s high-performing, high-value oncology network for their employees.

Under Section 5 of the Executive Order, President Trump requires HHS to, within 180 days of the date of the Executive Order (April 15, 2025), publish in the Federal Register a plan to conduct a survey to "determine the hospital acquisition cost for covered outpatient drugs at hospital outpatient departments."

Medicare has slashed physician reimbursement again. Unless Congress takes swift and meaningful action, we could see the unraveling of independent medical practices across the country.

Food and Drug Administration databases that physicians and public health experts rely on for key drug safety and manufacturing information have been neglected due to DOGE-directed layoffs, leaving health professionals flying blind on basic questions about certain drugs they're prescribing, current and former FDA officials tell Axios.

Bispecific antibodies have reshaped treatment approaches in relapsed multiple myeloma, but delivering them in a community setting comes with logistical and clinical hurdles.